SEARCH

SEARCH BY CITATION

References

  • Anderson, J.E., Appelbaum, F.R., Fisher, L.D., Schoch, G., Shulman, H., Anasetti, C., Bensinger, W.I., Bryant, E., Buckner, C.D., Doney, K., Martin, P.J., Sanders, J.E., Sullivan, K.M., Thomas, E.D., Witherspoon, R.P., Hansen, J.A. & Storb, R. (1993) Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome. Blood, 82, 677681.
  • Arnold, R., De Witte, T., Van Biezen, Hermans, J., Jacobsen, N., Runde, V., Gratwohl, A. & Apperley, J.F. (1998) Unrelated bone marrow transplantation in patients with myelodysplastic syndromes and secondary acute myeloid leukemia. An EBMT survey. Bone Marrow Transplantation, 21, 12131216.
  • Bennet, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnik, H.R., Sultan, C. & Cox, C. (1994) The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid and chronic myelomonocytic leukaemia. Proposal by the French–American–British Co-operative Leukaemia group. British Journal of Haematology, 87, 746754.
  • Beran, M., Kantarjian, H., O'Brien, S., Koller, S., Al-Bitar, M., Arbuck, S., Pierce, S., Moore, M., Abruzzese, J.L., Andreef, M., Keating, M. & Estey, E. (1996) Topotecan, a topoisomerase I inhibitor, is active in the treatment of myelodysplastic syndrome and chronic myelomonocytic leukemia. Blood, 88, 24732479.
  • Cambier, N., Wattel, E., Menot, M.L., Guerci, A., Chomienne, C. & Fenaux, P. (1996) All-trans retinoic acid in adult chronic myelomonocytic leukemia: results of a pilot study. Leukemia, 10, 11641167.
  • De Witte, T., Hermans, J., Vossen, J., Bacigalupo, A., Meloni, G., Jacobsen, N., Ruutu, T., Ljungman, P., Gratwohl, A., Runde, V., Niederwieser, D., Van Biezen, A., Devergie, A., Cornelissen, J., Jouet, J.P., Arnold, R. & Apperley, J. (2000) Haematopoietic stem cell transplantation for patients with myelodysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). British Journal of Haematology, 110, 620630.
  • Deeg, H.J., Shulman, H.M., Anderson, J.E., Bryant, E.M., Gooley, T.A., Anasetti, C., Fefer, A., Storb, R. & Appelbaum, F.R. (2000) Allogeneic and syngeneic marrow transplantation for myelodysplastic syndrome in patients 55–66 years of age. Blood, 95, 11881194.
  • Germing, U., Gattermann, N., Minning, H., Heyll, A. & Aul, C. (1998) Problems in the classification of CMML-dysplastic versus proliferative type. Leukemia Research, 22, 871878.DOI: 10.1016/S0145-2126(97)00192-6
  • Giralt, S., Hester, J., Huh, Y., Hirsch Ginsberg, C., Rondon, G., Seaong, D., Lee, M., Gajewski, J., Van Besien, K., Khouri, I., Mehra, R., Przepiorka, D., Talpaz, M., Kantarjian, H., Fischer, H., Deisseroth, A. & Champlin, R. (1995) CD8 depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation. Blood, 86, 43374343.
  • Giralt, S., Estey, E., Albitar, M., Van Besien, K., Rondon, K., Anderlini, P., O'Brien, S., Khouri, I., Gajewski, J., Mehra, R., Claxton, D., Andersson, B., Beran, M., Przepiorka, D., Koller, C., Kornblau, S., Korbling, M., Keating, M., Kantarjian, H. & Champlin, R. (1997) Engraftment of allogeneic hematopoietic progenitor cells with purin analog-containing chemotherapy: Harnessing graft versus leukemia effect without myeloablative therapy. Blood, 89, 45314536.
  • Greenberg, P., Cox, C., LeBeau, M.M., Fenaux, P., Morel, P., Sanz, G., Sanz, M., Vallespi, T., Hamblin, T., Oscier, D., Ohyashiki, K., Toyama, K., Aul, C., Mufti, G. & Bennett, J. (1997) International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood, 89, 20792088.
  • Harris, N.L., Jaffe, E.S., Diebold, J., Flandrin, G., Muller-Hermelink, H.K., Lister, T.A. & Bloomfield, C.D. (1999) The World Health Organization classification of neoplastic disease of the hematopoietic and lymphoid tissues. Annals of Oncology, 10, 14191432.
  • Kröger, N., Zabelina, T., Krüger, W., Renges, H., Stute, N., Schrum, J., Kabisch, H., Siegert, W. & Zander, A.R. (2001) A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome. Bone Marrow Transplantation, 15, 643647.
  • Locatelli, F., Niemeyer, C., Angelucci, E., Bender-Götze, C., Burdach, S., Ebell, W., Friedrich, W., Hasle, H., Hermann, J., Jacobsen, N., Klingebiel, T., Kremens, B., Mann, G., Pession, A., Peters, C., Schmid, H.J., Stary, J., Suttorp, M., Uderzo, C., Van't Veer-Korthof, E.T., Vossen, J., Zecca, M. & Zimmermann, M. for the European Working Group on Myelodysplastic Syndrome in Childhood (1997) Allogeneic bone marrow transplantation for chronic myelomonocytic leukemia in childhood: a report from the European Working Group on Myelodysplastic Syndrome in Childhood. Journal of Clinical Oncology, 15, 566573.
  • McSweeney, P., Niederwieser, D., Shizuru, J.A., Sandmaier, B.M., Molina, A.J., Maloney, D.G., Chauncey, T.R., Gooley, T.A., Hegenbart, U., Nash, R.A., Wagner, J.L., Minor, S., Appelbaum, F.R., Bensinger, W.I., Bryant, E., Flowers, M.E., Georges, G.E., Grumet, F.C., Kiem, H.P., Torok-Storb, B., Yu, B. & Storb, R.F. (2001) Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft- versus- tumor effects. Blood, 97, 33903400.
  • Ribera, J.M., Cervantes, F. & Rozman, C. (1987) A multivariate analysis of prognostic factors in chronic myelomonocytic leukaemia according the FAB criteria. British Journal of Haematology, 74, 395399.
  • Runde, V., De Witte, T., Arnold, R., Gratwohl, A., Hermans, J., Van Biezen, K., Niederwieser, D., Labopin, M., Walter-Noel, M.P., Bacigalupo, A., Jacobsen, N., Ljungman, P., Carreras, E., Kolb, H.J., Aul, C. & Apperley, A.J. on behalf of the Chronic Leukemia Working Party of The European Group for Blood and Marrow Transplantation (1998) Bone marrow transplantation from HLA-identical sibling as first line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome. Bone Marrow Transplantation, 21, 255261.
  • Runde, V., De Witte, T. & Brand, R. (2000) Chromosomal characteristics are an independent risk factor for relapse after HLA-identical sibling transplantation in patients with myelodysplastic syndromes (MDS) or secondary acute myeloid leukemia. Blood, 96, 2250a.
  • Slavin, S., Nagler, A., Naperstek, E., Kapelushnik, Y., Aker, M., Cividalli, G., Varadi, G., Kirschbaum, M., Ackerstein, A., Samuel, S., Amar, A., Brautbar, C., Ben-Tal, O., Eldor, A. & Or, R. (1998) Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant diseases. Blood, 91, 756763.
  • Tiberghien, P., Reynolds, C.W., Keller, J., Spence, S., Deschaseaux, M., Certoux, J.M., Contassot, E., Murphy, W.J., Lyons, R. & Chiang, Y. (1994) Gancivlovir treatment of herpes simplex thymidine kinase transduced primary T-lymphocytes: an approach for specific in vivo donor T-cell depletion after bone marrow transplantation? Blood, 84, 13331337.
  • Voglova, J., Chrobak, L., Neuwirtova, T.L., Malaskova, V. & Straka, L. (2001) Myelodysplastic and myeloproliferative type of chronic myelomonocytic leukemia-distinct subgroups or two stages of the same disease? Leukemia Research, 25, 493496 .DOI: 10.1016/S0145-2126(00)00159-4
  • Wattel, E., Guerci, A., Hecquet, B., Economopoulos, T., Copplestone, A., Mahe, B., Couteaux, M.E., Resegotti, L., Voglova, V., Foussard, C., Pegourie, B., Michaux, J.L., Deconinck, E., Stoppa, A.M., Mufti, G., Oscier, G., Fenaux, P. & Groupe francais des Myelodyslasie and European CMML Group (1996) A randomized trial of hydroxyurea versus VP 16 in adult chronic myelomonocytic leukemia. Blood, 88, 24802487.
  • Zang, D.Y., Deeg, H.J., Gooley, T., Anderson, J.E., Anasetti, C., Sanders, J., Myerson, D., Storb, R. & Appelbaum, F. (2000) Treatment of chronic myelomonocytic leukaemia by allogeneic marrow transplantation. British Journal of Haematology, 110, 217222.